🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 41150V103
- Market Cap
- Micro Cap · $14 Million
- Previous Symbol
- HEPH (changed 2/18/2010)
- Previous Name
- Hollis-Eden Pharmaceuticals, Inc.
Business: Harbor BioSciences is a development-stage company with two product candidates in clinical trials: Apoptone (HE3235), in the cohort expansion portion of a Phase I/IIa trial of patients with late-stage prostate cancer, and Triolex®, in a Phase IIa trial in obese type 2 diabetes mellitus patients. Apoptone and Triolex represent the lead candidates from Harbor BioSciences' small molecule platform based on metabolites or synthetic analogs of endogenous steroid hormones.
Company Contact
- CEO
- James M. Frincke, Ph.D.
- CFO
- Robert Weber
- Headquarters
- 4435 Eastgate Mall, Suite 400, San Diego, CA 92121
- Phone
- 858-587-9333
- Fax
- 858-558-6470
- Investor Relations
- Robert Weber · 858-587-9333 · rweber@harborbiosciences.com